The Cooper Companies, Inc. $COO Shares Acquired by AIA Group Ltd

AIA Group Ltd increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 53.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 37,278 shares of the medical device company’s stock after buying an additional 13,052 shares during the quarter. AIA Group Ltd’s holdings in Cooper Companies were worth $2,665,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in COO. New York Life Investment Management LLC boosted its stake in Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares in the last quarter. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares in the last quarter. Allworth Financial LP raised its stake in shares of Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after buying an additional 167 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after buying an additional 185 shares during the period. Finally, SJS Investment Consulting Inc. lifted its holdings in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO stock opened at $71.71 on Monday. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a 50-day moving average of $66.24 and a two-hundred day moving average of $72.52. The firm has a market capitalization of $13.99 billion, a PE ratio of 60.77, a P/E/G ratio of 1.87 and a beta of 0.84. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the firm posted $0.96 earnings per share. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on COO shares. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Robert W. Baird dropped their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Finally, Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.